← Back to patent-cliff list
奥美沙坦酯
Tier C — Watch / tradeOlmesartan Medoxomil
第一三共株式会社
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：AT1
Brand：Openvas、Benicar、Olmetec、Benevas、Olvance、傲坦
Indications (approved)：高血压
Regional status
US
批准上市
2002-04-25
EU
无进展
2001-11-01
China
批准上市
2006-04-06
Japan
批准上市
2004-01-29
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Olmesartan Medoxomil?
Approved indications include: 高血压.
When does the Olmesartan Medoxomil patent expire?
No public expiry year is available for Olmesartan Medoxomil yet; this page updates once verified.
How do I get a quote for Olmesartan Medoxomil intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25